Experimental Antiviral for COVID-19 Effective in Hamster Study

The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.

COVAX warns SARS-CoV-2 is reminder viruses by their very nature mutate

The emergence of variants of SARS-CoV-2, the virus that causes COVID-19, serve as a powerful reminder that viruses by their very nature mutate, and that the scientific response may need to adapt to remain effective against them, according to COVAX statement on new variants of SARS-CoV-2.